How Can Specialty Pharmacies Benefit from Clinical Outcomes Data?


Brandon Newman, PharmD, CSP, Program Director, Vanderbilt Specialty Pharmacy, discusses why clinical outcomes data are important for specialty pharmacies.

Newman: I think that as a specialty pharmacy industry we’ve been really dependent on metrics such as MPR (medication possession ratio) and (PDC) proportion of days covered—things that we can get from traditional specialty pharmacy claims data, dispense data.

But I think what we’re being challenged to do is really show good outcomes. What we can’t measure in claims data is outcomes, so I think that’s really going to be the next thing we need to focus on.

Related Videos
pharmacy oncology, Image Credit: © Konstantin Yuganov -
Pharmacist holding medicine box in pharmacy drugstore. | Image Credit: I Viewfinder -
Pharmacy Drugstore Checkout Cashier Counter | Image Credit: Gorodenkoff -
Mayo Clinic oncology pharmacy
Therapy session -- Image credit: pressmaster |
Testicular cancer and prostate cancer concept. | Image Credit: kenchiro168 -
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk -
© 2024 MJH Life Sciences

All rights reserved.